Master bibliography — migraine

Last audited: 2026-08-30. One line per unique paper cited across the migraine wiki, grouped by the paper’s first major topic. Every PMID below was re-fetched through live PubMed E-utilities in the audit session. Cross-cutting papers appear once; cited by records every wiki-page reference.

Companion evidence files: guidelines/REGISTRY.md, statistics/STATISTICS.md, patient-voice/, and notes/.

Foundations, diagnosis and burden

• Lipton RB, et al. Ubrogepant versus placebo in ACHIEVE II. JAMA. 2019. PMID 31742631 — tags: [acute-treatment, clinical-trials-landscape, overview] — cited by: acute-treatment.md, clinical-trials-landscape.md, overview.md
• VanderPluym JH, et al. Acute treatments for episodic migraine in adults: systematic review and meta-analysis. JAMA. 2021. PMID 34128998 — tags: [acute-treatment, neuromodulation-and-behavioral-care, overview] — cited by: acute-treatment.md, neuromodulation-and-behavioral-care.md, overview.md
• Karlsson WK, et al. Comparative effects of drug interventions for acute migraine: systematic review and network meta-analysis. BMJ. 2024. PMID 39293828 — tags: [acute-treatment, overview] — cited by: acute-treatment.md, overview.md
• Fraser CL, et al. Migraine aura: pathophysiology, mimics, and treatment options. Semin Neurol. 2019. PMID 31847045 — tags: [aura-and-cortical-spreading-depolarization, overview] — cited by: aura-and-cortical-spreading-depolarization.md, overview.md
• van Dongen RM, et al. Migraine biomarkers in cerebrospinal fluid: systematic review and meta-analysis. Cephalalgia. 2017. PMID 26888294 — tags: [biomarkers, overview] — cited by: biomarkers.md, overview.md
• Ashina M, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021. PMID 33773610 — tags: [biomarkers, overview, preventive-treatment, trigeminovascular-biology-and-cgrp] — cited by: biomarkers.md, overview.md, preventive-treatment.md, trigeminovascular-biology-and-cgrp.md
• Häppölä P, et al. Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia. 2022;42:345-356. PMID 34648375 — tags: [biomarkers, classification-and-diagnosis] — cited by: biomarkers.md, classification-and-diagnosis.md
• Hautakangas H, et al. Genome-wide analysis of 102,084 migraine cases identifies 123 loci. Nat Genet. 2022. PMID 35115687 — tags: [biomarkers, overview] — cited by: biomarkers.md, overview.md
• Bigal ME, et al. Migraine chronification: concept and risk factors. Curr Pain Headache Rep. 2009. PMID 19833063 — tags: [chronic-migraine-and-chronification, overview] — cited by: chronic-migraine-and-chronification.md, overview.md
• Dodick DW, et al. OnabotulinumtoxinA for chronic migraine: pooled PREEMPT results. Headache. 2010. PMID 20487038 — tags: [chronic-migraine-and-chronification, overview] — cited by: chronic-migraine-and-chronification.md, overview.md
• Adams AM, et al. The impact of chronic migraine: CaMEO methods and baseline results. Cephalalgia. 2015;35:563-578. PMID 25304766 — tags: [chronic-migraine-and-chronification, epidemiology-and-burden] — cited by: chronic-migraine-and-chronification.md, epidemiology-and-burden.md
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016. PMID 27389092 — tags: [chronic-migraine-and-chronification, overview] — cited by: chronic-migraine-and-chronification.md, overview.md
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. PMID 29368949 — tags: [chronic-migraine-and-chronification, classification-and-diagnosis, medication-overuse-headache, overview] — cited by: chronic-migraine-and-chronification.md, classification-and-diagnosis.md, medication-overuse-headache.md, overview.md
• Lipton RB, et al. Eptinezumab in chronic migraine: PROMISE-2. Neurology. 2020. PMID 32209650 — tags: [chronic-migraine-and-chronification, clinical-trials-landscape, overview, preventive-treatment] — cited by: chronic-migraine-and-chronification.md, clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Schwedt TJ, et al. Medication overuse and headache burden: CaMEO. Neurol Clin Pract. 2021;11:216-226. PMID 34476122 — tags: [chronic-migraine-and-chronification, epidemiology-and-burden] — cited by: chronic-migraine-and-chronification.md, epidemiology-and-burden.md
• Lewis DW, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches. Neurology. 2002;59:490-498. PMID 12196640 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Lipton RB, et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61:375-382. PMID 12913201 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Eriksen MK, et al. Sensitivity and specificity of the new international diagnostic criteria for migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:212-217. PMID 15654035 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Dong Z, et al. Validation of a guideline-based decision support system for diagnosis of primary headache disorders based on ICHD-3 beta. J Headache Pain. 2014;15:40. PMID 24934331 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Li D, et al. Field-testing of the ICHD-3 beta/proposed ICD-11 diagnostic criteria for migraine with aura. Cephalalgia. 2015;35:748-756. PMID 25424707 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Wang X, et al. Validation of the Chinese version of ID-Migraine and systematic review with meta-analysis concerning its diagnostic accuracy. J Oral Facial Pain Headache. 2015;29:265-278. PMID 26244435 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Lebedeva ER, et al. Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks. Cephalalgia. 2018;38:561-567. PMID 28372496 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Mattos ACMT, et al. ID-Migraine questionnaire and accurate diagnosis of migraine. Arq Neuropsiquiatr. 2017. PMID 28746431 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Lebedeva ER, et al. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. Cephalalgia. 2018;38:1463-1470. PMID 28994605 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Tinsley A, Rothrock JF. What are we missing in the diagnostic criteria for migraine? Curr Pain Headache Rep. 2018;22:84. PMID 30291572 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Munoz-Ceron J, et al. Headache at the emergency room: etiologies, diagnostic usefulness of ICHD-3 criteria, red and green flags. PLoS One. 2019;14:e0208728. PMID 30615622 — tags: [classification-and-diagnosis, red-flags-and-safety-concerns] — cited by: classification-and-diagnosis.md, red-flags-and-safety-concerns.md
• Papetti L, et al. Features of primary chronic headache in children and adolescents and validity of ICHD-3 criteria. Front Neurol. 2019;10:92. PMID 30890994 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Evans RW, et al. Neuroimaging for migraine: American Headache Society systematic review and evidence-based guideline. Headache. 2020;60:318-336. PMID 31891197 — tags: [classification-and-diagnosis, guidelines, red-flags-and-safety-concerns] — cited by: classification-and-diagnosis.md, guidelines.md, red-flags-and-safety-concerns.md
• Lempert T, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2022;32:1-6. PMID 34719447 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Verhagen IE, et al. Validation of diagnostic ICHD-3 criteria for menstrual migraine. Cephalalgia. 2022;42:1184-1193. PMID 35514214 — tags: [classification-and-diagnosis, sex-hormones-pregnancy-and-lactation] — cited by: classification-and-diagnosis.md, sex-hormones-pregnancy-and-lactation.md
• Ashina S, et al. Medication overuse headache. Nat Rev Dis Primers. 2023;9:5. PMID 36732518 — tags: [classification-and-diagnosis, guidelines, medication-overuse-headache, overview, red-flags-and-safety-concerns] — cited by: classification-and-diagnosis.md, guidelines.md, medication-overuse-headache.md, overview.md, red-flags-and-safety-concerns.md
• Kellier DJ, et al. Validity of self-reported migraine in adolescents and children. Headache. 2023;63:634-641. PMID 37140013 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Chalmer MA, et al. Population-based characterization of menstrual migraine and proposed diagnostic criteria. JAMA Netw Open. 2023;6:e2313235. PMID 37184838 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Sahu P, et al. Translation and validation of ID-Migraine questionnaire to North-Indian vernacular languages. Ann Indian Acad Neurol. 2023;26:543-548. PMID 37970241 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Paemeleire K, et al. Migraine without aura. Handb Clin Neurol. 2023;198:151-167. PMID 38043959 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Olesen J. The International Classification of Headache Disorders: History and future perspectives. Cephalalgia. 2024;44:3331024231214731. PMID 38166472 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• de Boer I, et al. Hemiplegic migraine. Handb Clin Neurol. 2024;199:353-365. PMID 38307656 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Scutelnic A, et al. Field-testing the explicit diagnostic criteria for transient ischemic attack: a diagnostic accuracy study. J Neurol. 2024. PMID 39680237 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Joppeková Ľ, et al. What does a migraine aura look like? A systematic review. J Headache Pain. 2025;26:149. PMID 40597581 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Robblee J, et al. Redefining status migrainosus: a narrative review. Headache. 2026. PMID 41902388 — tags: [classification-and-diagnosis] — cited by: classification-and-diagnosis.md
• Goadsby PJ, et al. Controlled trial of erenumab for episodic migraine. N Engl J Med. 2017. PMID 29171821 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Dodick DW, et al. Fremanezumab for prevention of episodic migraine. JAMA. 2018. PMID 29800211 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Stauffer VL, et al. Galcanezumab for prevention of episodic migraine: EVOLVE-1. JAMA Neurol. 2018. PMID 29813147 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Croop R, et al. Oral rimegepant for preventive treatment of migraine. Lancet. 2021. PMID 33338437 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Reuter U, et al. Erenumab versus topiramate for migraine prevention. Cephalalgia. 2022. PMID 34743579 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Buse DC, et al. Sleep disorders among people with migraine: CaMEO. Headache. 2019;59:32-45. PMID 30381821 — tags: [comorbidity-and-vascular-risk, epidemiology-and-burden] — cited by: comorbidity-and-vascular-risk.md, epidemiology-and-burden.md
• Zhang S, et al. Association between migraine and risk of stroke: systematic review and meta-analysis. Neurol Sci. 2022. PMID 35451664 — tags: [comorbidity-and-vascular-risk, overview] — cited by: comorbidity-and-vascular-risk.md, overview.md
• Silberstein SD. Epidemiology of migraine. Neuroepidemiology. 1993. PMID 8272178 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Lipton RB, et al. Prevalence and impact of migraine. Neurol Clin. 1997;15:1-13. PMID 9058393 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Vos T, et al. Years lived with disability for 1160 sequelae of 289 diseases and injuries, 1990-2010. Lancet. 2012;380:2163-2196. PMID 23245607 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Woldeamanuel YW, et al. Prevalence of migraine headache and its weight on neurological burden in Africa. J Neurol Sci. 2014;342:1-15. PMID 24814950 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Buse DC, et al. Impact of migraine on the family: perspectives of people with migraine and partners in CaMEO. Mayo Clin Proc. 2016. PMID 27132088 — tags: [epidemiology-and-burden, patient-experience-and-advocacy] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md
• Lipton RB, et al. Family impact of migraine: development of the IMPAC scale. Headache. 2017;57:570-585. PMID 28185239 — tags: [epidemiology-and-burden, patient-experience-and-advocacy] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md
• GBD 2016 Collaborators. Global, regional, and national incidence, prevalence, and YLDs for 328 diseases and injuries, 1990-2016. Lancet. 2017;390:1211-1259. PMID 28919117 — tags: [epidemiology-and-burden, overview] — cited by: epidemiology-and-burden.md, overview.md
• Buse DC, et al. Adolescent perspectives on the burden of a parent's migraine: CaMEO. Headache. 2018;58:512-524. PMID 29355924 — tags: [epidemiology-and-burden, patient-experience-and-advocacy] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md
• Katsarava Z, et al. Poor medical care for people with migraine in Europe: evidence from the Eurolight study. J Headache Pain. 2018;19:10. PMID 29392600 — tags: [epidemiology-and-burden, patient-experience-and-advocacy] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md
• Steiner TJ, et al. The HURT questionnaire, an outcome measure to guide follow-up in primary care. J Headache Pain. 2018;19:15. PMID 29445880 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016. Lancet Neurol. 2018;17:954-976. PMID 30353868 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016. Lancet Neurol. 2019;18:459-480. PMID 30879893 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Buse DC, et al. Life with migraine: effects on relationships, career, and finances from CaMEO. Headache. 2019;59:1286-1299. PMID 31407321 — tags: [epidemiology-and-burden, patient-experience-and-advocacy] — cited by: epidemiology-and-burden.md, patient-experience-and-advocacy.md
• Lipton RB, et al. Discontinuation of acute prescription medication for migraine: CaMEO. Headache. 2019;59:1762-1772. PMID 31544244 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Hutchinson S, et al. Characterization of acute prescription migraine medication use: CaMEO. Mayo Clin Proc. 2020;95:709-718. PMID 32247344 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Lipton RB, et al. Characterizing opioid use in a US population with migraine: CaMEO. Neurology. 2020;95:e457-e468. PMID 32527971 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Feigin VL, et al. Burden of neurological disorders across the US from 1990-2017. JAMA Neurol. 2021;78:165-176. PMID 33136137 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Adams AM, et al. CaMEO-International: methods and multi-country baseline findings for diagnosis rates and care. Cephalalgia. 2023;43:3331024231180611. PMID 37314231 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Leonardi M, et al. Societal and personal impact of migraine. Handb Clin Neurol. 2023;198:23-29. PMID 38043966 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Simmonds L, et al. Epidemiology of migraine. Handb Clin Neurol. 2023;198:31-38. PMID 38043969 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Dong L, et al. The global burden of migraine: a 30-year trend review and future projections. Pain Ther. 2025;14:297-315. PMID 39661241 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• GBD 2023 Headache Collaborators. Global, regional, and national burden of headache disorders, 1990-2023. Lancet Neurol. 2025;24:1005-1015. PMID 41240916 — tags: [epidemiology-and-burden] — cited by: epidemiology-and-burden.md
• Oskoui M, et al. Pharmacologic treatment for pediatric migraine prevention: guideline update. Neurology. 2019. PMID 31413170 — tags: [guidelines, migraine-in-children-and-adolescents, overview] — cited by: guidelines.md, migraine-in-children-and-adolescents.md, overview.md
• Oskoui M, et al. Acute treatment of migraine in children and adolescents: guideline update. Neurology. 2019. PMID 31413171 — tags: [guidelines, migraine-in-children-and-adolescents, overview] — cited by: guidelines.md, migraine-in-children-and-adolescents.md, overview.md
• Bae JY, et al. Cognitive behavioral therapy for migraine: systematic review and meta-analysis. Medicina. 2021. PMID 35056352 — tags: [neuromodulation-and-behavioral-care, overview] — cited by: neuromodulation-and-behavioral-care.md, overview.md
• Anttila V, et al. Genetics of migraine. Handb Clin Neurol. 2018. PMID 29478595 — tags: [overview] — cited by: overview.md
• Burch R. Menstrual migraine and migraine during pregnancy and lactation. Headache. 2020. PMID 31579938 — tags: [overview, sex-hormones-pregnancy-and-lactation] — cited by: overview.md, sex-hormones-pregnancy-and-lactation.md
• Ashina M, et al. Eptinezumab after two-to-four preventive failures: DELIVER. Lancet Neurol. 2022. PMID 35716692 — tags: [overview, preventive-treatment] — cited by: overview.md, preventive-treatment.md

Mechanisms, aura and biomarkers

• Ashina M, et al. Migraine and the trigeminovascular system—40 years and counting. Lancet Neurol. 2019. PMID 31160203 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Maniyar FH, Goadsby PJ. The premonitory phase of migraine—what can we learn from it? Headache. 2015. PMID 25919990 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Schankin CJ, et al. Visual snow—persistent positive visual phenomenon distinct from migraine aura. Curr Pain Headache Rep. 2015. PMID 26021756 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Aurora SK, et al. Migraine: imaging the aura. Curr Opin Neurol. 2000. PMID 10871250 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Smith JM, et al. Physiological studies of cortical spreading depression. Biol Rev Camb Philos Soc. 2006. PMID 16848916 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Pezzini A, et al. The migraine-ischemic stroke connection: potential pathogenic mechanisms. Curr Mol Med. 2009. PMID 19275630 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Eikermann-Haerter K, Ayata C. Cortical spreading depression and migraine. Curr Neurol Neurosci Rep. 2010. PMID 20425031 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Gandini MA, et al. Channeling headache: Ca2+ channels and familial hemiplegic migraine type 1. Channels. 2012. PMID 22991044 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Bruen R, et al. Persistent migraine aura in an adolescent girl. J AAPOS. 2013. PMID 23871134 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Hansen JM, et al. CGRP and migraine with aura: a systematic review. Cephalalgia. 2014. PMID 24452423 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Erdener ŞE, Dalkara T. Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol. 2014. PMID 24611635 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Eikermann-Haerter K. Spreading depolarization may link migraine and stroke. Headache. 2014. PMID 24913618 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Cui Y, et al. Role of cortical spreading depression in migraine pathophysiology. Neurosci Bull. 2014. PMID 25260797 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Harriott AM, et al. Dissecting the association between migraine and stroke. Curr Neurol Neurosci Rep. 2015. PMID 25652090 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Østergaard L, et al. Neurovascular coupling during cortical spreading depolarization and depression. Stroke. 2015. PMID 25882051 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• de Falco FA, et al. Migraine with aura: which patients are most at risk of stroke? Neurol Sci. 2015. PMID 26017513 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Tegetmeyer H. Visual snow syndrome: symptoms and ophthalmological findings. Klin Monbl Augenheilkd. 2017. PMID 27508888 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Zarcone D, et al. Shared mechanisms of epilepsy, migraine and affective disorders. Neurol Sci. 2017. PMID 28527083 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Metzler AI, Robertson CE. Visual snow syndrome: proposed criteria, clinical implications, and pathophysiology. Curr Neurol Neurosci Rep. 2018. PMID 29934719 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Charles A. The migraine aura. Continuum. 2018. PMID 30074546 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Tolner EA, et al. Current understanding of cortical structure and function in migraine. Cephalalgia. 2019. PMID 30922081 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Yemisci M, et al. Aura and stroke: relationship and lessons from preclinical models. J Headache Pain. 2019. PMID 31142262 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Major S, et al. Direct electrophysiological evidence that spreading depolarization-induced depression is the correlate of migraine aura. Geroscience. 2020. PMID 31820363 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Lucas C. Migraine with aura. Rev Neurol (Paris). 2021. PMID 34384631 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Eren OE, et al. Visual phenomena associated with migraine and their differential diagnosis. Dtsch Arztebl Int. 2021. PMID 34636719 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Erdener ŞE, et al. Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. J Headache Pain. 2021. PMID 34794382 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Robertson CE, et al. Persistent aura, visual snow, and other visual symptoms. Handb Clin Neurol. 2024. PMID 38307662 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Christensen RH, et al. Meningeal brain borders and migraine headache genesis. Trends Neurosci. 2024. PMID 39304416 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Kitamura A, et al. Molecular and cellular neurobiology of spreading depolarization/depression and migraine. Int J Mol Sci. 2024. PMID 39456943 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Brighina F, et al. Cortical inhibition and habituation to evoked potentials in migraine. J Headache Pain. 2009. PMID 19209386 — tags: [biomarkers] — cited by: biomarkers.md
• Cady RK, et al. Salivary CGRP during acute migraine predicts rizatriptan response. Headache. 2009. PMID 19788468 — tags: [biomarkers] — cited by: biomarkers.md
• Coppola G, et al. Cortical excitability in chronic migraine. Curr Pain Headache Rep. 2012. PMID 22076672 — tags: [biomarkers] — cited by: biomarkers.md
• Chen WT, et al. Magnetoencephalography in chronic migraine. Curr Pain Headache Rep. 2013. PMID 23250794 — tags: [biomarkers] — cited by: biomarkers.md
• Demarquay G, et al. Neurophysiological evaluation of cortical excitability in migraine. Rev Neurol (Paris). 2013. PMID 23602117 — tags: [biomarkers] — cited by: biomarkers.md
• Cady RK, et al. Salivary CGRP and onabotulinumtoxinA in chronic migraine. Headache. 2014. PMID 24147647 — tags: [biomarkers] — cited by: biomarkers.md
• Chong CD, et al. Migraine classification using resting-state functional connectivity. Cephalalgia. 2017. PMID 27306407 — tags: [biomarkers] — cited by: biomarkers.md
• Christensen CE, et al. Migraine induction with CGRP in patients from erenumab trials. J Headache Pain. 2018. PMID 30409109 — tags: [biomarkers, trigeminovascular-biology-and-cgrp] — cited by: biomarkers.md, trigeminovascular-biology-and-cgrp.md
• Coppola G, et al. Clinical neurophysiology of migraine with aura. J Headache Pain. 2019. PMID 31035929 — tags: [biomarkers] — cited by: biomarkers.md
• Aroke EN, et al. Metabolomics of chronic pain conditions: systematic review. Biol Res Nurs. 2020. PMID 32666804 — tags: [biomarkers] — cited by: biomarkers.md
• Yan Z, et al. Biomarkers in migraine. Neurol India. 2021. PMID 34003145 — tags: [biomarkers] — cited by: biomarkers.md
• Ferreira KS, et al. Potential biomarkers in migraine: review and new insights. Expert Rev Neurother. 2021. PMID 34210227 — tags: [biomarkers] — cited by: biomarkers.md
• Loonen ICM, et al. Plasma lipid changes after cortical spreading depolarization in FHM mice. Metabolites. 2022. PMID 35323663 — tags: [biomarkers] — cited by: biomarkers.md
• Basedau H, et al. Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target. eLife. 2022. PMID 35604755 — tags: [biomarkers, trigeminovascular-biology-and-cgrp] — cited by: biomarkers.md, trigeminovascular-biology-and-cgrp.md
• Chaturvedi S, et al. Role of omics in migraine research and management. Mol Neurobiol. 2022. PMID 35796901 — tags: [biomarkers] — cited by: biomarkers.md
• Gomez-Pilar J, et al. EEG/MRI/PET biomarkers differentiating chronic and episodic migraine. J Headache Pain. 2022. PMID 35927625 — tags: [biomarkers] — cited by: biomarkers.md
• Rahman Siddiquee MM, et al. Headache classification and biomarker extraction from structural MRI using deep learning. Brain Commun. 2023. PMID 36751567 — tags: [biomarkers] — cited by: biomarkers.md
• Messina R, et al. Imaging brain and vascular reactions to headache treatments. J Headache Pain. 2023. PMID 37221469 — tags: [biomarkers] — cited by: biomarkers.md
• Karlsson WK, et al. REFORM biomarker study methodology and baseline characteristics. J Headache Pain. 2023. PMID 37303034 — tags: [biomarkers, clinical-trials-landscape, trigeminovascular-biology-and-cgrp] — cited by: biomarkers.md, clinical-trials-landscape.md, trigeminovascular-biology-and-cgrp.md
• Puledda F, et al. Electrophysiological findings and abnormal synaptic plasticity in migraine. Cephalalgia. 2023. PMID 37622421 — tags: [biomarkers] — cited by: biomarkers.md
• Al-Khazali HM, et al. Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab. Cephalalgia. 2024. PMID 38859744 — tags: [biomarkers, trigeminovascular-biology-and-cgrp] — cited by: biomarkers.md, trigeminovascular-biology-and-cgrp.md
• Karlsson WK, et al. Plasma suPAR and therapeutic response to erenumab: a REFORM study. J Headache Pain. 2025. PMID 40275185 — tags: [biomarkers] — cited by: biomarkers.md
• Uzun N, et al. Lamotrigine prophylaxis is associated with reduced aura frequency in burdensome migraine aura. Front Neurol. 2026. PMID 42591364 — tags: [aura-and-cortical-spreading-depolarization] — cited by: aura-and-cortical-spreading-depolarization.md
• Ulutas M, et al. Evoked-potential studies in migraine: systematic review. Cephalalgia. 2025. PMID 41364425 — tags: [biomarkers] — cited by: biomarkers.md
• Strassman AM, Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006. PMID 16492942 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Zhang X, et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther. 2007. PMID 17483291 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Levy D, et al. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci. 2008. PMID 18333963 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Zhang X, et al. TNF-α induces sensitization of meningeal nociceptors via local COX and p38 MAP kinase actions. Pain. 2011. PMID 21036476 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Raddant AC, Russo AF. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med. 2011. PMID 22123247 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Burstein R, et al. The science of migraine. J Vestib Res. 2011. PMID 22348935 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Charles A. The evolution of a migraine attack. Headache. 2013. PMID 23278169 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Zhang X, et al. Vascular ERK mediates migraine-related sensitization of meningeal nociceptors. Ann Neurol. 2013. PMID 23447360 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Karsan N, et al. CGRP mechanism antagonists and migraine management. Curr Neurol Neurosci Rep. 2015. PMID 25790955 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Karsan N, et al. Calcitonin gene-related peptide and migraine. Curr Opin Neurol. 2015. PMID 25887765 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Schulte LH, May A. The migraine generator revisited: continuous scanning over 30 days and three spontaneous attacks. Brain. 2016. PMID 27190019 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Guo S, et al. The role of genetics on migraine induction triggered by CGRP and PACAP38. Dan Med J. 2017. PMID 28260603 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Labastida-Ramírez A, et al. Gender aspects of CGRP in migraine. Cephalalgia. 2019. PMID 29082826 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol. 2018. PMID 29568973 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Marone IM, et al. TRPA1/NOX in trigeminal ganglion neurons mediates glyceryl-trinitrate migraine-related pain in mice. Brain. 2018. PMID 29985973 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Karsan N, Goadsby PJ. The migraine premonitory phase. Continuum. 2018. PMID 30074545 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Iyengar S, et al. CGRP and the trigeminal system in migraine. Headache. 2019. PMID 30982963 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Noseda R, et al. Fluorescently-labelled fremanezumab distributes to ganglia and dura but not brain in rats with intact BBB. Cephalalgia. 2020. PMID 31856583 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• de Vries T, et al. Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther. 2020. PMID 32173558 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• Karsan N, Goadsby PJ. Imaging the premonitory phase of migraine. Front Neurol. 2020. PMID 32269547 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md
• González-Hernández A, et al. Locus of action of CGRPergic monoclonal antibodies: peripheral over central mechanisms. CNS Neurol Disord Drug Targets. 2020. PMID 32552657 — tags: [trigeminovascular-biology-and-cgrp] — cited by: trigeminovascular-biology-and-cgrp.md

Acute, preventive and chronic-care evidence

• Smith LA, et al. Eletriptan for acute migraine. Cochrane Database Syst Rev. 2001. PMID 11687056 — tags: [acute-treatment] — cited by: acute-treatment.md
• McCrory DC, et al. Oral sumatriptan for acute migraine. Cochrane Database Syst Rev. 2003. PMID 12917936 — tags: [acute-treatment] — cited by: acute-treatment.md
• Mathew NT, et al. Tolerability and safety of eletriptan in migraine. Headache. 2003. PMID 14511273 — tags: [acute-treatment] — cited by: acute-treatment.md
• Dodick DW, et al. Cardiovascular tolerability and safety of triptans: review of clinical data. Headache. 2004. PMID 15149490 — tags: [acute-treatment, red-flags-and-safety-concerns] — cited by: acute-treatment.md, red-flags-and-safety-concerns.md
• Derry CJ, et al. Sumatriptan (oral) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012. PMID 22336849 — tags: [acute-treatment] — cited by: acute-treatment.md
• Derry CJ, et al. Sumatriptan (intranasal) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012. PMID 22336867 — tags: [acute-treatment] — cited by: acute-treatment.md
• Derry CJ, et al. Sumatriptan (rectal) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012. PMID 22336868 — tags: [acute-treatment] — cited by: acute-treatment.md
• Derry CJ, et al. Sumatriptan (subcutaneous) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012. PMID 22336869 — tags: [acute-treatment] — cited by: acute-treatment.md
• Bird S, et al. Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev. 2014. PMID 24848613 — tags: [acute-treatment] — cited by: acute-treatment.md
• Tajti J, et al. Drug safety in acute migraine treatment. Expert Opin Drug Saf. 2015. PMID 25773005 — tags: [acute-treatment, red-flags-and-safety-concerns] — cited by: acute-treatment.md, red-flags-and-safety-concerns.md
• Richer L, et al. Drugs for acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016. PMID 27091010 — tags: [acute-treatment, migraine-in-children-and-adolescents] — cited by: acute-treatment.md, migraine-in-children-and-adolescents.md
• Maasumi K, et al. Menstrual migraine and treatment options. Headache. 2017. PMID 27910087 — tags: [acute-treatment, sex-hormones-pregnancy-and-lactation] — cited by: acute-treatment.md, sex-hormones-pregnancy-and-lactation.md
• Rubio-Beltrán E, et al. Is selective 5-HT1F receptor agonism distinct from triptans? Pharmacol Ther. 2018. PMID 29352859 — tags: [acute-treatment] — cited by: acute-treatment.md
• Negro A, et al. Gepants for treatment of migraine. Expert Opin Investig Drugs. 2019. PMID 31081399 — tags: [acute-treatment] — cited by: acute-treatment.md
• Tepper SJ, et al. Characterization of dizziness after lasmiditan: SAMURAI and SPARTAN. Headache. 2019. PMID 31152441 — tags: [acute-treatment] — cited by: acute-treatment.md
• Krege JH, et al. Safety findings from phase 3 lasmiditan studies. Cephalalgia. 2019. PMID 31166697 — tags: [acute-treatment] — cited by: acute-treatment.md
• Croop R, et al. Rimegepant ODT for acute migraine: randomized phase 3 trial. Lancet. 2019. PMID 31311674 — tags: [acute-treatment, clinical-trials-landscape] — cited by: acute-treatment.md, clinical-trials-landscape.md
• Loo LS, et al. Lasmiditan efficacy and safety with concomitant preventive medication: SAMURAI and SPARTAN. J Headache Pain. 2019. PMID 31340760 — tags: [acute-treatment] — cited by: acute-treatment.md
• Loo LS, et al. Rescue or recurrence dose of lasmiditan: SAMURAI and SPARTAN. BMC Neurol. 2019. PMID 31409292 — tags: [acute-treatment] — cited by: acute-treatment.md
• Negro A, et al. Novel synthetic treatment options for migraine. Expert Opin Pharmacother. 2021. PMID 33369482 — tags: [acute-treatment] — cited by: acute-treatment.md
• Beauchene JK, et al. Lasmiditan: acute migraine treatment without vasoconstriction. J Pharm Technol. 2021. PMID 34752575 — tags: [acute-treatment] — cited by: acute-treatment.md
• Lipton RB, et al. Zavegepant 10 mg nasal spray for acute migraine: phase 3 trial. Lancet Neurol. 2023. PMID 36804093 — tags: [acute-treatment, clinical-trials-landscape] — cited by: acute-treatment.md, clinical-trials-landscape.md
• Aurora SK, et al. PREEMPT 1 randomized phase. Cephalalgia. 2010. PMID 20647170 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Diener HC, et al. PREEMPT 2 randomized phase. Cephalalgia. 2010. PMID 20647171 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Aurora SK, et al. Pooled 56-week PREEMPT program. Headache. 2011. PMID 21883197 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Silberstein SD, et al. PREEMPT subgroup with acute-medication overuse. J Neurol Sci. 2013. PMID 23790235 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Aurora SK, et al. Five treatment cycles in PREEMPT. Acta Neurol Scand. 2014. PMID 24107267 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Whitcup SM, et al. Development of onabotulinumtoxinA for chronic migraine. Ann N Y Acad Sci. 2014. PMID 25399521 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Pedraza MI, et al. OnabotulinumtoxinA in 52 chronic-migraine patients using PREEMPT paradigm. Springerplus. 2015. PMID 25897415 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Lipton RB, et al. OnabotulinumtoxinA improves quality of life over one year: PREEMPT. Cephalalgia. 2016. PMID 27288354 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Chiang CC, et al. OnabotulinumtoxinA in chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord. 2017. PMID 29204191 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Green MW, et al. PREEMPT-derived versus customized injection paradigm. Toxicon. 2018. PMID 29596847 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Buse DC, et al. Migraine progression: a systematic review. Headache. 2019. PMID 30589090 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Jackson JL, et al. Beta-blockers for prevention of headache: systematic review. PLoS One. 2019. PMID 30893319 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Deen M, et al. Adherence to IHS chronic-migraine preventive-trial guidelines. Cephalalgia. 2019. PMID 31042062 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Forbes RB, et al. Efficacy and contextual effects of CGRP antibodies: meta-analysis. Headache. 2020. PMID 32668023 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Drellia K, et al. Anti-CGRP monoclonal antibodies: likelihood to help or harm analysis. Cephalalgia. 2021. PMID 33567891 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Giri S, et al. Topiramate, botulinum toxin A and CGRP antibodies in chronic migraine with MOH. Cephalalgia. 2023. PMID 36856015 — tags: [chronic-migraine-and-chronification, medication-overuse-headache] — cited by: chronic-migraine-and-chronification.md, medication-overuse-headache.md
• Sirilertmekasakul P, et al. Transition from medication overuse after anti-CGRP antibodies. Neurol Sci. 2024. PMID 38564060 — tags: [chronic-migraine-and-chronification, medication-overuse-headache] — cited by: chronic-migraine-and-chronification.md, medication-overuse-headache.md
• Oliveira AB, et al. CGRP-targeted medication in chronic migraine: systematic review. J Headache Pain. 2024. PMID 38575868 — tags: [chronic-migraine-and-chronification] — cited by: chronic-migraine-and-chronification.md
• Stovner LJ, et al. Candesartan versus propranolol for migraine prophylaxis. Cephalalgia. 2014. PMID 24335848 — tags: [clinical-trials-landscape, preventive-treatment] — cited by: clinical-trials-landscape.md, preventive-treatment.md
• Charles AC, et al. CGRP-targeting therapies are a first-line option: AHS position statement update. Headache. 2024. PMID 38466028 — tags: [guidelines, preventive-treatment] — cited by: guidelines.md, preventive-treatment.md
• Radat F, et al. Psychiatric comorbidity in evolution from migraine to MOH. Cephalalgia. 2005. PMID 15955038 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Rossi P, et al. Advice versus structured detoxification in low-medical-need transformed migraine. Cephalalgia. 2006. PMID 16919060 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Hagen K, et al. Management of MOH: one-year randomized multicentre trial. Cephalalgia. 2009. PMID 18823363 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Bøe MG, et al. Chronic daily headache with medication overuse: neurologist versus primary-care follow-up. Cephalalgia. 2009. PMID 19228151 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Sances G, et al. Risk factors in MOH: one-year follow-up. Cephalalgia. 2010. PMID 19614697 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Okada-Ogawa A, et al. Morphine-induced sensitization in dura-sensitive medullary neurons. J Neurosci. 2009. PMID 20016098 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Hagen K, et al. Randomized trial on MOH: outcome after one and four years. Acta Neurol Scand Suppl. 2011. PMID 21711255 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Rossi P, et al. Advice versus structured detoxification for complicated MOH. J Headache Pain. 2013. PMID 23565591 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Cheung V, Amoozegar F. Medication overuse headache. Curr Neurol Neurosci Rep. 2015. PMID 25398377 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Chiang CC, et al. Treatment of medication-overuse headache: systematic review. Cephalalgia. 2016. PMID 26122645 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Kristoffersen ES, et al. Predictors of successful primary-care detoxification. Acta Neurol Scand. 2017. PMID 28369734 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Schwedt TJ, et al. Factors associated with acute medication overuse: MAST study. J Headache Pain. 2018. PMID 29797100 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Pijpers JA, et al. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse. Brain. 2019. PMID 30982843 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Carlsen LN, et al. Comparison of three treatment strategies for MOH: randomized trial. JAMA Neurol. 2020. PMID 32453406 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• González-Oria C, et al. Revision and updating of medication overuse headache. Neurologia. 2021. PMID 32917437 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Rouw C, et al. Dependence-like behaviour in patients treated for MOH. Eur J Pain. 2021. PMID 33326656 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Carlsen LN, et al. Treatment of MOH: effect and predictors after one year. Headache. 2021. PMID 34325483 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Corand V, et al. French recommendations for MOH treatment strategies. Rev Neurol (Paris). 2021. PMID 34332779 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Chen XY, et al. Gray-matter alteration in MOH: ALE meta-analysis. Brain Imaging Behav. 2022. PMID 35143020 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Diener HC, et al. Mobile-software prevention of medication overuse and MOH: trial protocol. Trials. 2022. PMID 35546412 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Kaltseis K, et al. Prednisone for withdrawal headache in the CGRP-antibody era. Headache. 2022. PMID 36437611 — tags: [medication-overuse-headache] — cited by: medication-overuse-headache.md
• Stetter F, Kupper S. Autogenic training: meta-analysis of clinical outcome studies. Appl Psychophysiol Biofeedback. 2002. PMID 12001885 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Lipton RB, et al. Single-pulse TMS for acute migraine with aura: sham-controlled trial. Lancet Neurol. 2010. PMID 20206581 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Schwedt TJ. Occipital nerve stimulation for chronic migraine: interpreting ONSTIM. Cephalalgia. 2011. PMID 20847083 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: randomized trial. Pain Physician. 2012. PMID 22622909 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Schoenen J, et al. Migraine prevention with a supraorbital transcutaneous stimulator. Neurology. 2013. PMID 23390177 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Slotty PJ, et al. Occipital nerve stimulation: randomized trial of subthreshold stimulation. Cephalalgia. 2015. PMID 24812035 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Russo A, et al. Transcutaneous supraorbital neurostimulation in de novo migraine. J Headache Pain. 2015. PMID 26197977 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Silberstein SD, et al. Chronic migraine prevention with non-invasive vagus stimulation: EVENT. Neurology. 2016. PMID 27412146 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Chou DE, et al. External trigeminal nerve stimulation for acute migraine: open-label trial. Neuromodulation. 2017. PMID 28580703 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Gu Q, et al. Mindfulness meditation for primary headache pain: meta-analysis. Chin Med J. 2018. PMID 29578127 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Tassorelli C, et al. Non-invasive vagus nerve stimulation as acute migraine therapy: PRESTO. Neurology. 2018. PMID 29907608 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Jiang L, et al. Flunarizine plus transcutaneous supraorbital neurostimulation. Acta Neurol Scand. 2019. PMID 30428122 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Chou DE, et al. Acute migraine therapy with external trigeminal neurostimulation: ACME. Cephalalgia. 2019. PMID 30449151 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Lee HJ, et al. Psychological treatment for headache disorder: systematic review and meta-analysis. J Headache Pain. 2019. PMID 30764752 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Yarnitsky D, et al. Remote electrical neuromodulation relieves acute migraine. Headache. 2019. PMID 31074005 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Robblee J, Starling AJ. SEEDS for success: lifestyle management in migraine. Cleve Clin J Med. 2019. PMID 31710587 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Lai YH, et al. Cervical non-invasive vagus stimulation for migraine and cluster headache. Neuromodulation. 2020. PMID 32166843 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Perlini C, et al. Implementation of psychological interventions for chronic headache. BMC Health Serv Res. 2020. PMID 32450871 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Vekhter D, et al. Behavioral treatments for migraine and pain in acute care. Curr Pain Headache Rep. 2020. PMID 32979092 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Pei JH, et al. Mindfulness-based cognitive therapy for chronic pain. Psychol Health Med. 2021. PMID 33241941 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Clark O, et al. Non-invasive neuromodulation in acute migraine: systematic review and meta-analysis. Neurol Sci. 2022. PMID 34698941 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Huang Y, et al. Effects of non-pharmacologic placebo treatments on migraine prevention. Acta Neurol Belg. 2024. PMID 38245660 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Orr SL, et al. REN for pediatric migraine in the emergency department: randomized pilot. Headache. 2025. PMID 39290050 — tags: [neuromodulation-and-behavioral-care] — cited by: neuromodulation-and-behavioral-care.md
• Tronvik E, et al. Candesartan for migraine prophylaxis: randomized controlled trial. JAMA. 2003. PMID 12503978 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev. 2004. PMID 15266476 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Jackson JL, et al. Comparative effectiveness meta-analysis of drugs for migraine prophylaxis. PLoS One. 2015. PMID 26172390 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Mitsikostas DD, et al. CGRP monoclonal antibodies: comparisons across randomized studies. Curr Opin Neurol. 2017. PMID 28240610 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Xu XM, et al. Antidepressants for prevention of migraine in adults: meta-analysis. Eur J Neurol. 2017. PMID 28557171 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Israel H, et al. CGRP monoclonal antibodies for preventive treatment. Curr Pain Headache Rep. 2018. PMID 29623520 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Goadsby PJ. Primary headache disorders: five new things. Neurol Clin Pract. 2019. PMID 31341711 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Moreno-Ajona D, et al. Gepants: what could be their role in migraine treatment? Curr Opin Neurol. 2020. PMID 32251023 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Schoenen J, et al. Monoclonal antibodies blocking CGRP transmission: added value in prevention. Rev Neurol (Paris). 2020. PMID 32758365 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Gklinos P, et al. Role of galcanezumab in migraine prevention. Pharmaceuticals. 2021. PMID 33803190 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Mavridis T, et al. CGRP monoclonal antibodies from clinical studies to real-world evidence. Pharmaceuticals. 2021. PMID 34358126 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Ehrlich M, et al. Erenumab versus topiramate: post-hoc efficacy analysis from HER-MES. J Headache Pain. 2022. PMID 36380284 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Messina R, et al. Safety and tolerability of CGRP antibodies and gepants: network meta-analysis. Cephalalgia. 2023. PMID 36786548 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Haghdoost F, et al. Efficacy of CGRP mAbs and gepants: network meta-analysis. Cephalalgia. 2023. PMID 36855951 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Lampl C, et al. Comparative effectiveness of migraine preventive drugs: systematic review and network meta-analysis. J Headache Pain. 2023. PMID 37208596 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Cho SJ, et al. Update of gepants in chronic migraine. Curr Pain Headache Rep. 2023. PMID 37656319 — tags: [preventive-treatment] — cited by: preventive-treatment.md
• Reuter U, et al. Atogepant versus topiramate for migraine prevention: TEMPLE randomized head-to-head trial. Lancet Neurol. 2026. PMID 42492556 — tags: [clinical-trials-landscape, overview, preventive-treatment] — cited by: clinical-trials-landscape.md, overview.md, preventive-treatment.md
• Sarvari Soltani M, et al. Dual-mechanism onabotulinumtoxinA and anti-CGRP antibody prevention: exploratory meta-analysis. Eur J Med Res. 2026. PMID 41721358 — tags: [chronic-migraine-and-chronification, preventive-treatment] — cited by: chronic-migraine-and-chronification.md, preventive-treatment.md
• Silvestro M, et al. OnabotulinumtoxinA after CGRP-antibody treatment failure: multicentre real-world experience. Toxins (Basel). 2026. PMID 42646770 — tags: [preventive-treatment] — cited by: preventive-treatment.md

Populations, comorbidity and safety

• Powers SW, et al. CBT plus amitriptyline for pediatric chronic migraine. JAMA. 2013. PMID 24368463 — tags: [clinical-trials-landscape, migraine-in-children-and-adolescents] — cited by: clinical-trials-landscape.md, migraine-in-children-and-adolescents.md
• Elbadawi A, et al. PFO closure for migraine: meta-analysis of randomized trials. Acta Cardiol. 2019. PMID 29914296 — tags: [clinical-trials-landscape, comorbidity-and-vascular-risk] — cited by: clinical-trials-landscape.md, comorbidity-and-vascular-risk.md
• Diener HC, et al. Patent foramen ovale and migraine. Curr Pain Headache Rep. 2007. PMID 17504652 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Amouroux R, et al. Anxiety and depression in children and adolescents with migraine. Encephale. 2008. PMID 19068340 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Schürks M, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009. PMID 19861375 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Schürks M, et al. Migraine and mortality: systematic review and meta-analysis. Cephalalgia. 2011. PMID 21803936 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Balottin U, et al. Psychopathological symptoms in child/adolescent migraine: meta-analysis. Cephalalgia. 2013. PMID 23203505 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Smitherman TA, et al. Panic disorder and migraine: comorbidity and implications. Headache. 2013. PMID 23278473 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Nyholt DR, et al. Concordance of genetic risk across migraine subgroups. Cephalalgia. 2015. PMID 25179292 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Keezer MR, et al. Comorbid relationship between migraine and epilepsy: systematic review and meta-analysis. Eur J Neurol. 2015. PMID 25495495 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Sacco S, et al. Migraine and risk of ischaemic heart disease: systematic review and meta-analysis. Eur J Neurol. 2015. PMID 25808832 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Tariq N, et al. Patent foramen ovale and migraine: closing the debate. Headache. 2016. PMID 26952049 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Friedman LE, et al. Migraine and suicidal ideation: systematic review and meta-analysis. Clin J Pain. 2017. PMID 27648590 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Tietjen GE, et al. Hypercoagulability and migraine. Headache. 2018. PMID 28181217 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Hildick-Smith D, Williams TM. Patent foramen ovale and migraine headache. Interv Cardiol Clin. 2017. PMID 28886844 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Magalhães JE, et al. Migraine and cerebrovascular diseases: epidemiology and clinical considerations. Headache. 2018. PMID 30117565 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Rammohan K, et al. Migraine and mood disorders: prevalence, correlations and disability. J Neurosci Rural Pract. 2019. PMID 30765967 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Giblett JP, et al. Patent foramen ovale closure in 2019. Interv Cardiol. 2019. PMID 30858890 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Subota A, et al. Postictal signs and symptoms in epilepsy: systematic review and meta-analysis. Epilepsy Behav. 2019. PMID 30978637 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Sullivan DP, et al. Psychological sleep interventions for migraine and tension-type headache. Sci Rep. 2019. PMID 31015531 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Kleykamp BA, et al. Psychiatric and chronic-pain comorbidities in fibromyalgia. Semin Arthritis Rheum. 2021. PMID 33383293 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Affatato O, et al. OnabotulinumtoxinA in comorbid migraine and depression: meta-analysis. J Transl Med. 2021. PMID 33789668 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Ng CY, et al. Myocardial infarction, stroke and cardiovascular mortality among migraine patients. J Neurol. 2022. PMID 34997286 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Hershey AD, et al. PedMIDAS: development of a pediatric migraine disability questionnaire. Neurology. 2001. PMID 11739822 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Hershey AD. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc. 2005. PMID 15928347 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Winner P. Epidemiology and diagnosis of migraine in children. Curr Pain Headache Rep. 2007. PMID 17894928 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Bruijn J, et al. Psychopathology in children and adolescents with migraine: systematic review. Pediatrics. 2010. PMID 20603260 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Babineau SE, Green MW. Headaches in children. Continuum. 2012. PMID 22868546 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Sun H, et al. Migraine therapeutics in adolescents: systematic analysis of triptan trials. JAMA Pediatr. 2013. PMID 23359002 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Wöber-Bingöl Ç. Pharmacological treatment of acute migraine in adolescents and children. Paediatr Drugs. 2013. PMID 23575981 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Heyer GL, et al. PedMIDAS scoring underestimates disability on non-school days. Headache. 2014. PMID 24708311 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Kroner JW, et al. CBT plus amitriptyline reduces pediatric chronic migraine to ≤4 days/month. Headache. 2016. PMID 26992129 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Powers SW, et al. Amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017. PMID 27788026 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Kroon Van Diest AM, et al. Treatment adherence in the CBT and amitriptyline trial. Clin J Pain. 2017. PMID 28118256 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Eidlitz Markus T, et al. Obesity and migraine in childhood. Curr Pain Headache Rep. 2018. PMID 29725875 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Slater SK, et al. Migraine in children: presentation, disability and response to treatment. Curr Opin Pediatr. 2018. PMID 30234648 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Locher C, et al. Pharmacologic treatments for pediatric migraine prophylaxis: network meta-analysis. JAMA Pediatr. 2020. PMID 32040139 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Alqahtani MM, et al. Approach to pediatric intractable migraine. Curr Neurol Neurosci Rep. 2021. PMID 34089140 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Reidy BL, et al. Treatment response trajectories in CHAMP. Cephalalgia. 2022. PMID 34404270 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Iannone LF, et al. Emerging pharmacological treatments for migraine in pediatrics. Life. 2022. PMID 35455026 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Peterson J, et al. Evaluation and management of paediatric vertigo. Curr Opin Otolaryngol Head Neck Surg. 2022. PMID 36165009 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• VanderPluym JH, et al. Treatments on the horizon for migraine in children and adolescents. Neurology. 2023. PMID 37604658 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Abu-Arafeh I, et al. Migraine in children and adolescents: assessment and diagnosis. Handb Clin Neurol. 2024. PMID 38307664 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Orr SL. Headache in children and adolescents. Continuum. 2024. PMID 38568493 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Pavitt S, et al. Repetitive dihydroergotamine infusions with preventive adjustment in pediatric chronic headache. J Headache Pain. 2025. PMID 40301763 — tags: [migraine-in-children-and-adolescents] — cited by: migraine-in-children-and-adolescents.md
• Gül M, et al. Cerebrovascular risk with CGRP monoclonal antibodies versus onabotulinumtoxinA in migraine. Cephalalgia. 2026. PMID 42390441 — tags: [comorbidity-and-vascular-risk] — cited by: comorbidity-and-vascular-risk.md
• Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002. PMID 11754714 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Debette S, Leys D. Cervical-artery dissections. Lancet Neurol. 2009. PMID 19539238 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Klein AM, Loder E. Postpartum headache. Int J Obstet Anesth. 2010. PMID 20833030 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Bellolio MF, et al. External validation of the Ottawa SAH rule. Am J Emerg Med. 2015. PMID 25511365 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Debette S, et al. Intracranial artery dissection. Lancet Neurol. 2015. PMID 25987283 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Briet C, et al. Pituitary apoplexy. Endocr Rev. 2015. PMID 26414232 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Buttgereit F, et al. Polymyalgia rheumatica and giant cell arteritis: systematic review. JAMA. 2016. PMID 27299619 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Zuurbier SM, et al. Cerebral venous thrombosis. Adv Exp Med Biol. 2017. PMID 27628005 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Negro A, et al. Headache and pregnancy: systematic review. J Headache Pain. 2017. PMID 29052046 — tags: [red-flags-and-safety-concerns, sex-hormones-pregnancy-and-lactation] — cited by: red-flags-and-safety-concerns.md, sex-hormones-pregnancy-and-lactation.md
• Anzola GP, et al. Postpartum headache: prospective study. J Oral Facial Pain Headache. 2017. PMID 29073663 — tags: [red-flags-and-safety-concerns, sex-hormones-pregnancy-and-lactation] — cited by: red-flags-and-safety-concerns.md, sex-hormones-pregnancy-and-lactation.md
• Robbins MS. Headache in pregnancy. Continuum. 2018. PMID 30074551 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Do TP, et al. Red and orange flags for secondary headaches: SNNOOP10. Neurology. 2019. PMID 30587518 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Flores-Sánchez BC, et al. Acute angle closure glaucoma. Br J Hosp Med. 2019. PMID 31822188 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Foley RW, et al. External validation of SAH rules in a UK cohort. Clin Med. 2021. PMID 33762366 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Aamodt AH, et al. Cerebral venous thrombosis. Semin Thromb Hemost. 2022. PMID 35170006 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Clark M, et al. Review of carotid and vertebral artery dissection. Br J Hosp Med. 2022. PMID 35506728 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Viera AJ, Antono B. Acute headache in adults: diagnostic approach. Am Fam Physician. 2022. PMID 36126007 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Saposnik G, et al. Diagnosis and management of cerebral venous thrombosis: AHA statement. Stroke. 2024. PMID 38284265 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Chu KH, et al. Predictive performance of common red flags in emergency headache. Emerg Med J. 2024. PMID 38658053 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Iglesias P. Pituitary apoplexy: updated review. J Clin Med. 2024. PMID 38731037 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Kim YJ, et al. Diagnostic pitfalls in reversible cerebral vasoconstriction syndrome. J Headache Pain. 2025. PMID 40289076 — tags: [red-flags-and-safety-concerns] — cited by: red-flags-and-safety-concerns.md
• Newman L, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine. Headache. 2001. PMID 11264684 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Sances G, et al. Course of migraine during pregnancy and postpartum: prospective study. Cephalalgia. 2003. PMID 12662187 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Silberstein SD, et al. Frovatriptan for intermittent prevention of menstrual migraine. Neurology. 2004. PMID 15277618 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Ertresvåg JM, et al. Headache and transient focal neurological symptoms during pregnancy. Acta Neurol Scand. 2005. PMID 15740574 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Mannix LK, et al. Naratriptan for short-term prevention of menstrually related migraine. Headache. 2007. PMID 17635595 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Ashkenazi A, et al. Menstrual migraine: hormonal causes, prophylaxis and treatment. Expert Opin Pharmacother. 2007. PMID 17685879 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Markus F, et al. Frovatriptan review. Expert Opin Pharmacother. 2007. PMID 18001261 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Nezvalová-Henriksen K, et al. Triptan exposure during pregnancy: Norwegian cohort. Headache. 2010. PMID 20132339 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Kvisvik EV, et al. Headache and migraine during pregnancy and puerperium: MIGRA study. J Headache Pain. 2011. PMID 21442333 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Bérard A, et al. DHE use during gestation and adverse pregnancy outcomes. Headache. 2012. PMID 22612391 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• MacGregor EA. Frovatriptan for treatment of menstrual migraine. Int J Womens Health. 2014. PMID 24904224 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Silberstein SD, et al. Menstrual migraine: hormonal causes, prophylaxis and treatment. Expert Opin Pharmacother. 2014. PMID 25100506 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Marchenko A, et al. Pregnancy outcome after prenatal triptan exposure: meta-analysis. Headache. 2015. PMID 25644494 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Nierenburg H, et al. Preventive and acute treatment of menstrual migraine: systematic review. Headache. 2015. PMID 26264117 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Parazzini F, et al. Magnesium in gynecological practice: literature review. Magnes Res. 2017. PMID 28392498 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Todd C, Lagman-Bartolome AM. Women and migraine: role of hormones. Curr Neurol Neurosci Rep. 2018. PMID 29855724 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Yusuf A, et al. Electronic databases for pregnancy safety: triptan case study. Pharmacoepidemiol Drug Saf. 2018. PMID 30240072 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing recognition. Lancet Neurol. 2021. PMID 33600767 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Bérard A, et al. DHE and triptan use during pregnancy and adverse outcomes. Sci Rep. 2021. PMID 34588467 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md
• Nappi RE, et al. Role of estrogens in menstrual migraine. Cells. 2022. PMID 35456034 — tags: [sex-hormones-pregnancy-and-lactation] — cited by: sex-hormones-pregnancy-and-lactation.md

Guidelines, trials and patient experience

• García-Azorin D, et al. Endpoints in symptomatic primary-headache trials: systematic review. J Headache Pain. 2018. PMID 30242571 — tags: [clinical-trials-landscape, guidelines] — cited by: clinical-trials-landscape.md, guidelines.md
• Evers S, Jensen R. EFNS guideline on treatment of MOH. Eur J Neurol. 2011. PMID 21834901 — tags: [guidelines] — cited by: guidelines.md
• Silberstein SD, et al. AAN/AHS guideline: episodic migraine prevention in adults. Neurology. 2012. PMID 22529202 — tags: [guidelines] — cited by: guidelines.md
• Sarchielli P, et al. Italian guidelines for primary headaches: 2012 revision. J Headache Pain. 2012. PMID 22581120 — tags: [guidelines] — cited by: guidelines.md
• Loder E, et al. 2012 AHS/AAN prevention guidelines: comparison with other guidelines. Headache. 2012. PMID 22671714 — tags: [guidelines] — cited by: guidelines.md
• Pringsheim T, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012. PMID 22683887 — tags: [guidelines] — cited by: guidelines.md
• Martelletti P, et al. Neuromodulation of chronic headaches: EHF position statement. J Headache Pain. 2013. PMID 24144382 — tags: [guidelines] — cited by: guidelines.md
• Rajapakse T, Pringsheim T. Nutraceuticals in migraine: summary of guidelines. Headache. 2016. PMID 26954394 — tags: [guidelines] — cited by: guidelines.md
• Ahmed MA, et al. Practice recommendations for migraine in African adults. Pan Afr Med J. 2016. PMID 27642420 — tags: [guidelines] — cited by: guidelines.md
• Bendtsen L, et al. EHF onabotulinumtoxinA guideline for chronic migraine. J Headache Pain. 2018. PMID 30259200 — tags: [guidelines] — cited by: guidelines.md
• Eigenbrodt AK, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021. PMID 34145431 — tags: [guidelines] — cited by: guidelines.md
• Ailani J, et al. AHS consensus statement on integrating new migraine treatments. Headache. 2021. PMID 34160823 — tags: [guidelines] — cited by: guidelines.md
• Demarquay G, et al. French Headache Society adult migraine guideline, part 1. Rev Neurol (Paris). 2021. PMID 34340812 — tags: [guidelines] — cited by: guidelines.md
• Kristoffersen ES, et al. Headache knowledge among Norwegian GPs. J Headache Pain. 2021. PMID 34763647 — tags: [guidelines] — cited by: guidelines.md
• Sacco S, et al. EHF guideline on CGRP monoclonal antibodies: 2022 update. J Headache Pain. 2022. PMID 35690723 — tags: [guidelines] — cited by: guidelines.md
• Chiang CC, et al. Comparisons of 25 acute medicines from 10 million app records. Neurology. 2023. PMID 38030397 — tags: [guidelines] — cited by: guidelines.md
• Puledda F, et al. IHS global practice recommendations for acute pharmacological treatment. Cephalalgia. 2024. PMID 39133176 — tags: [guidelines] — cited by: guidelines.md
• Puledda F, et al. IHS global practice recommendations for preventive pharmacological treatment. Cephalalgia. 2024. PMID 39262214 — tags: [guidelines] — cited by: guidelines.md
• Moisset X, et al. Migraine treatment: French Headache Society position paper. Rev Neurol (Paris). 2024. PMID 39406556 — tags: [guidelines] — cited by: guidelines.md
• Ornello R, et al. Evidence-based guidelines for pharmacological treatment of migraine. Cephalalgia. 2025. PMID 40277319 — tags: [guidelines] — cited by: guidelines.md
• Sacco S, et al. Setting higher standards for migraine prevention: IHS position statement. Cephalalgia. 2025. PMID 39980456 — tags: [guidelines] — cited by: guidelines.md
• Qaseem A, et al. Pharmacologic treatments of acute episodic migraine in outpatient settings: ACP guideline. Ann Intern Med. 2025. PMID 40096690 — tags: [guidelines] — cited by: guidelines.md
• Qaseem A, et al. Prevention of episodic migraine using pharmacologic treatments in outpatient settings: ACP guideline. Ann Intern Med. 2025. PMID 39899861 — tags: [guidelines] — cited by: guidelines.md
• Yuan H, et al. IHS evidence-based guidelines on non-invasive neuromodulation devices for migraine. Cephalalgia. 2025. PMID 41117312 — tags: [guidelines] — cited by: guidelines.md
• Robblee J, et al. AHS guideline update to acute migraine treatment in the emergency department. Headache. 2026. PMID 41321235 — tags: [guidelines] — cited by: guidelines.md
• Braca S, et al. Sex-specific management of migraine: EHF systematic review and consensus statement. J Headache Pain. 2026. PMID 41998499 — tags: [guidelines, sex-hormones-pregnancy-and-lactation] — cited by: guidelines.md, sex-hormones-pregnancy-and-lactation.md
• Kennedy A, et al. BASH clinical practice recommendations for advanced migraine preventives. J Neurol Neurosurg Psychiatry. 2026. PMID 42469019 — tags: [guidelines] — cited by: guidelines.md
• Young WB, et al. The stigma of migraine. PLoS One. 2013. PMID 23342079 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Gonzalez JM, et al. Preferences for migraine treatment outcomes: choice experiment. Headache. 2013. PMID 23808578 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Loder S, et al. Migraine burden and treatment in US minority populations. Headache. 2015. PMID 25644596 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Palacios-Ceña D, et al. Living with chronic migraine: qualitative study. BMJ Open. 2017. PMID 28827275 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Leonardi M, et al. Burden of migraine as impact on people's lives. J Headache Pain. 2019. PMID 31023226 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Gibbs SN, et al. US patient perspective: My Migraine Voice survey. Headache. 2020. PMID 32369201 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Raffaelli B, et al. Perception of migraine images on the internet. J Med Internet Res. 2021. PMID 34766918 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Matsumori Y, et al. Burden of migraine in Japan: OVERCOME. Neurol Ther. 2022. PMID 34862581 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Heidari F, et al. Common themes of patient experiences with migraine. Prim Care Companion CNS Disord. 2022. PMID 35254739 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Hubig LT, et al. Measuring interictal burden among people with migraine. J Headache Pain. 2022. PMID 35941572 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Seng EK, et al. Unique role of stigma in migraine disability and quality of life. Headache. 2022. PMID 36321956 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Gerstein MT, et al. Patient experiences with migraine-related cognitive symptoms: MiCOAS. Headache. 2023. PMID 36905166 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Mangrum R, et al. Priority acute and preventive treatment benefits: MiCOAS. Headache. 2023. PMID 37140142 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Uçan Tokuç FE, et al. Internal stigmatization in chronic migraine and MOH. BMC Neurol. 2024. PMID 38500111 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• McInnarney A, et al. Patient perceptions of barriers to migraine management in Aotearoa New Zealand. J Prim Health Care. 2024. PMID 39704768 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Takizawa T, et al. Dual ictal and interictal burden: OVERCOME Japan. J Headache Pain. 2025. PMID 40524160 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Goadsby PJ, et al. Migraine stigma and general knowledge: European survey. Cephalalgia. 2025. PMID 40891742 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Randerson KL, et al. Primary-care clinician perspectives in Aotearoa New Zealand. J Prim Health Care. 2025. PMID 41134026 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Hutchinson S, et al. Unmet treatment needs in migraine: OVERCOME US. Headache. 2026. PMID 41721442 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md
• Ng JY, et al. The social life of migraine: meta-ethnography of lived experience. Health Serv Insights. 2026. PMID 42256516 — tags: [patient-experience-and-advocacy] — cited by: patient-experience-and-advocacy.md

Coverage note

• Unique PMIDs: 388.
• Bibliographic wording is inherited from the page reference lists; PMID is the authoritative record key.
• ClinicalTrials.gov records are catalogued in wiki/clinical-trials-landscape.md and are not duplicated here because they are registry records, not papers.